Trade with Eva: Analytics in action >>

Tuesday, December 26, 2017

=Insys Therapeutics (INSY): granted Fast Track designation


  • Insys Therapeutics: FDA has granted Fast Track designation to the company's cannabidio oral solution for the treatment of Prader-Willi syndrome; co plans to start the clinical development program in late first quarter of 2018


No comments:

Post a Comment